Dr. Shanan Mahal, MD

Dr. Mahal practices at Saint Agnes Medical Center in Fresno, California, part of Trinity Health.

Dr. Mahal's NPI, 1548730260, was assigned on November 26, 2018. Dr. Mahal graduated from Southern Medical University in 2014. Dr. Mahal holds California license A178296.

Dr. Mahal's primary practice is Saint Agnes Medical Center, at 1303 E Herndon Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 450-3000.

Dr. Mahal's primary practice is Saint Agnes Medical Center in Fresno, California, part of Trinity Health. The medical group on file is Vituity. Dmand AI also links Dr. Mahal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahal practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Mahal's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Mahal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mahal's licenses on file in 3 states: California, Arkansas and Missouri.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, cardiac arrhythmia, cellulitis, chronic diabetes, circulatory problems in extremities and congestive heart failure among the conditions Dr. Mahal treats.

CMS data shows 36 Medicare services from Dr. Mahal across 1 procedure code in 2024, for 23 Medicare patients. Medicare paid $3,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Mahal in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahal's median patient age at 69, with 55% women.

In 2024, Dr. Mahal wrote 22 Medicare Part D claims for 11 patients. 82% of them were for generic drugs. They cover 2 drugs, with $6,196 in total drug cost. In 2022, CMS named 112 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Mahal for performance year 2024, reported as part of a group. Dr. Mahal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Mahal, published from 2018 to 2021. 2018 was the busiest year, with 2. Dr. Mahal has published most often in Cureus. Dr. Mahal's most frequent co-authors are Sorabh Datta, MD, Bipin Kumar Saroha, MD and Angela R. Driskill, MD.

CMS Open Payments shows 2 general payments to Dr. Mahal from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Mylan Inc. paid the most, $147.

Dr. Mahal graduated from Southern Medical University in 2014. Dr. Mahal is a member of ACP and AMA.

Dr. Mahal is in network with 3 carriers, including Aetna, Elevance and AR State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.